ReviewFrontiers in medicine2020

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.

Federica Saponaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.